A congressional watchdog agency has concluded the Food and Drug Administration properly conducted a review of the controversial Mifeprex abortion pill before relaxing usage guidelines two years ago, a move that prompted complaints by some lawmakers and anti-abortion activists that the shift was politically motivated.
The finding comes amid ongoing tumult over Mifeprex, which was once known as RU-486 and remains a focal point of a long-running cultural clash in the U.S. over access to medically induced abortion. In the final months of the Obama administration, however, the FDA eased its guidelines, allowing women to use the pill further into pregnancy and with fewer visits to their doctor.
About the Author Reprints
